Last reviewed · How we verify
NCT04005417
Meta-analysis of Stannous Fluoride Dentifrice and the Effects on Dentine Hypersensitivity
trial testing Stannous fluoride dentifrice in Dentine Hypersensitivity in 1,036 participants. Completed in 30 November 2018.
30 November 2018
Quick facts
| Lead sponsor | Procter and Gamble |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,036 |
| Start date | 8 January 2018 |
| Primary completion | 30 November 2018 |
| Estimated completion | 30 November 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Stannous fluoride dentifrice — full drug profile →
- Positive control dentifrice — full drug profile →
- Negative control dentifrice — full drug profile →
Conditions studied
- Dentine Hypersensitivity — all drugs for Dentine Hypersensitivity →
Sponsor
Procter and Gamble — full company profile →
Who can join
18 and older, any sex, with Dentine Hypersensitivity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this 11 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) on dentine hypersensitivity versus a positive or negative control dentifrice.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04005417
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Stannous fluoride dentifrice
Trials testing the same drug.
- NCT04006483 — Meta-analysis of Stannous Fluoride and the Effects on Dental Plaque · completed
- NCT04006470 — Meta-analysis of Stannous Fluoride and the Effects on Enamel Erosion · completed
Other recruiting trials for Dentine Hypersensitivity
Currently open trials in the same condition.
- NCT06633627 — Neurological Responses in Patients with Dentine Hypersensitivity · recruiting
Other Procter and Gamble trials
Trials by the same sponsor.
- NCT07158112 — Assessing Gingivitis and Plaque From a Marketed Toothpaste · Phase 4 · active not recruiting
- NCT06962956 — Evaluating Gingivitis and Systemic Biomarkers · Phase 1 · active not recruiting
- NCT06892834 — Assessing Gingivitis of 3 Different Dentifrices Compared to a Negative Control. · Phase 2 · completed
- NCT06140784 — A Clinical Study to Assess the Gingivitis and Plaque Effects of Various Dentifrices · NA · completed
- NCT06140758 — Evaluation of the Anticaries Efficacy of Dentifrice Formulations Using an In-situ Model · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04005417 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Procter and Gamble
- Last refreshed: 2 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04005417.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing